Demographics (1)
- SEX - Biological sex (phv00533332.v1.p1)
Disease Events (10)
- AFFECTION_STATUS - Case control status of the subject for acral melanoma; all subjects were acral melanoma patients. (phv00533336.v1.p1)
- AGE_AT_FIRST_DIAGNOSIS - Subject age at first diagnosis of tumor (phv00533338.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00533346.v2.p1)
- IS_TUMOR - Tumor status (phv00533345.v2.p1)
- PATIENT_STATUS - Patient being alive or not at last follow-up (phv00533340.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00533347.v2.p1)
- PRIMARY_THICKNESS - Thickness of the primary tumor (phv00533339.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00533348.v2.p1)
- SURVIVAL_TIME - Patient survival time after diagnosis (phv00533341.v1.p1)
- TREATMENT_BEFORE_EXCISION - Treatment(s) patient received before the excision of the specimen (phv00533349.v2.p1)
Race and Ethnicity (1)
- RACE - Race/ethnicity inferred from sequencing data (phv00533337.v1.p1)
Other (10)
- ANALYTE_TYPE - Analyte Type (phv00533344.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00533343.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00533331.v1.p1)
- DATA_TYPE - Whole-Exome-Seq, Whole-Genome-Seq, or Targeted-Seq (phv00541610.v1.p1)
- SAMPLE_ID - Sample ID (phv00533342.v2.p1)
- SAMPLE_ID - Sample ID (phv00533334.v2.p1)
- SAMPLE_TYPE - Normal or different tumor stages (phv00534473.v2.p1)
- SUBJECT_ID - Subject ID (phv00533335.v1.p1)
- SUBJECT_ID - Subject ID (phv00533330.v1.p1)
- SUBJECT_ID - Subject ID (phv00533333.v2.p1)